BioStat Solutions, Inc. Hires Dr. Karen Woodward

Nov. 8, 2011 - PRLog -- BioStat Solutions, Inc., is pleased to announce the appointment of Dr. Karen Woodward, to serve as its Business Development Manager for the North East Region. Dr. Woodward will serve on the Company's Business Development Team effective November 28th of 2011, and will develop sales strategies to market BSSI's analytical abilities in PGx studies.
Dr. Woodward has more than 15 years of experience in the life sciences and translational service markets during which she supported numerous worldwide strategic corporate and biotech accounts, established new business development, and assisted as the interface with clients in the areas of proteomics and multiplex assay development.
Dr. Woodward holds a Ph.D. in Microbiology & Molecular Genetics, from UMASS Medical Center, Worcester, MA along with several post-doctoral fellowships.  "We congratulate Karen on her appointment as our Business Development Manager for the North East Region. This important step further strengthens our corporate exposure in the upper Eastern seaboard," stated Mr. Bromley, CEO, BioStat Solutions, Inc. "Karen’s prior experience in both business development and personalized medicine will be instrumental in guiding our continued growth and strategic development initiatives."
Upon her appointment Dr. Woodward stated, "I look forward to working closely with the executive team of BioStat Solutions, Inc. as the Company moves through the next phase of business development and toward further market penetration. Transitioning to the Business Development Manager role for the Northern East Coast Region should allow Ron and his management team to focus the further expansion of the Company, thereby increasing value for BioStat Solutions, Inc."

About BioStat Solutions, Inc.
BioStat Solutions, Inc. is a statistical consulting company in service to pharmaceutical and biotechnology industries worldwide.  The BioStat Solutions, Inc. philosophy is to establish a collaborative biostatistical approach in the design and analytical support of pre-clinical/clinical trials for drugs, devices and biologics.  BioStat Solutions, Inc. provides an adaptive and interdisciplinary team, capable of implementing both complex and traditional methodologies, in the assessment of biological systems.. For more information, please visit BioStat Solutions Inc's website at www.biostatsolutions.com.

This release includes forward-looking statements on BioStat Solutions, Inc’s current expectations and projections about future events. In some cases forward-looking statements can be identified by terminology such as "may," "should," "potential," "continue," "expects," "anticipates," "intends," "plans," "believes," "estimates," and similar expressions. These statements are based upon current beliefs, expectations and assumptions and are subject to a number of risks and uncertainties, many of which are difficult to predict and include statements regarding the effects of appointing a Business Development Manager. The forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those set forth or implied by any forward-looking statements. The information in this release is provided only as of the date of this release, and BioStat Solutions, Inc’s undertakes no obligation to update any forward-looking statements contained in this release on account of new information, future events, or otherwise, except as required by law.  BioStat Solutions, Inc. is a privately held company and markets its services in the U.S. and internationally.